Brian L. VanderBeek

3.2k total citations · 1 hit paper
90 papers, 1.9k citations indexed

About

Brian L. VanderBeek is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Brian L. VanderBeek has authored 90 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Ophthalmology, 41 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Molecular Biology. Recurrent topics in Brian L. VanderBeek's work include Retinal Diseases and Treatments (47 papers), Retinal Imaging and Analysis (30 papers) and Glaucoma and retinal disorders (22 papers). Brian L. VanderBeek is often cited by papers focused on Retinal Diseases and Treatments (47 papers), Retinal Imaging and Analysis (30 papers) and Glaucoma and retinal disorders (22 papers). Brian L. VanderBeek collaborates with scholars based in United States, Ethiopia and Yemen. Brian L. VanderBeek's co-authors include Lucia Sobrin, Jennifer K. Sun, Emily Y. Chew, Sharon D. Solomon, Charles C. Wykoff, Elia J. Duh, Thomas W. Gardner, Yinxi Yu, Liyuan Ma and Mark W. Johnson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Care.

In The Last Decade

Brian L. VanderBeek

85 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diabetic Retinopathy: A Position Statement by the American Diabetes Association

2017 665 citations Lucia Sobrin, Jennifer K. Sun et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian L. VanderBeek United States	23	1.4k	970	208	167	131	90	1.9k
Clare Bailey United Kingdom	28	2.3k 1.7×	1.8k 1.8×	341 1.6×	106 0.6×	204 1.6×	99	2.9k
Mukharram M. Bikbov Germany	18	1.5k 1.1×	1.3k 1.3×	300 1.4×	171 1.0×	374 2.9×	140	2.3k
Leslie M. Niziol United States	25	1.8k 1.3×	1.3k 1.3×	175 0.8×	77 0.5×	192 1.5×	112	2.2k
Peter H. Scanlon United Kingdom	22	1.6k 1.2×	1.5k 1.6×	132 0.6×	202 1.2×	245 1.9×	66	2.1k
Miho Yasuda Japan	18	1.1k 0.8×	875 0.9×	177 0.9×	153 0.9×	316 2.4×	55	1.6k
C Alex Harper Australia	26	1.7k 1.2×	1.2k 1.2×	366 1.8×	323 1.9×	254 1.9×	68	2.4k
Sophie Rogers Australia	23	2.4k 1.8×	1.7k 1.7×	168 0.8×	173 1.0×	190 1.5×	52	3.0k
B.C.P. Polak Netherlands	25	1.3k 1.0×	999 1.0×	244 1.2×	362 2.2×	207 1.6×	62	2.2k
Jie Jin Wang Australia	15	1.3k 0.9×	918 0.9×	245 1.2×	38 0.2×	321 2.5×	17	1.7k
Roxanne Crosby‐Nwaobi United Kingdom	18	752 0.5×	591 0.6×	364 1.8×	82 0.5×	111 0.8×	25	1.3k

Countries citing papers authored by Brian L. VanderBeek

Since Specialization

Citations

This map shows the geographic impact of Brian L. VanderBeek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian L. VanderBeek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian L. VanderBeek more than expected).

Fields of papers citing papers by Brian L. VanderBeek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian L. VanderBeek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian L. VanderBeek. The network helps show where Brian L. VanderBeek may publish in the future.

Co-authorship network of co-authors of Brian L. VanderBeek

This figure shows the co-authorship network connecting the top 25 collaborators of Brian L. VanderBeek. A scholar is included among the top collaborators of Brian L. VanderBeek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian L. VanderBeek. Brian L. VanderBeek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dunaief, Joshua L., et al.. (2025). Association of Age-Related Macular Degeneration with Cholelithiasis. Ophthalmology Science. 5(4). 100771–100771. 1 indexed citations

VanderBeek, Brian L., Yinxi Yu, Serena Cardillo, & Rebecca A. Hubbard. (2025). Twenty-Year Trends in Prevalence and Incidence of Diabetic Retinal Disease. Ophthalmology. 132(7). 767–774. 2 indexed citations

VanderBeek, Brian L., et al.. (2025). Evaluation of ChatGPT-4 in detecting referable diabetic retinopathy using single fundus images. SHILAP Revista de lepidopterología. 2(2). 100111–100111. 1 indexed citations

Domalpally, Amitha, Ward Fickweiler, Kerry Goetz, et al.. (2024). Data Harmonization, Standardization, and Collaboration for Diabetic Retinal Disease (DRD) Research: Report From the 2024 Mary Tyler Moore Vision Initiative Workshop on Data. Translational Vision Science & Technology. 13(10). 4–4. 1 indexed citations

Tauqeer, Zujaja, et al.. (2024). Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic Retinopathy. Ophthalmic Epidemiology. 32(4). 390–393. 5 indexed citations

Miller, Charles G., et al.. (2023). SGLT2 inhibitors and diabetic retinopathy progression. Graefe s Archive for Clinical and Experimental Ophthalmology. 262(3). 753–758. 10 indexed citations

Briceño, César A., et al.. (2023). Risk Factors for Chalazion Diagnosis and Subsequent Surgical Excision. Ophthalmic Epidemiology. 31(1). 84–90. 3 indexed citations

Yu, Yinxi, et al.. (2023). Real-world socioeconomic determinants of corneal crosslinking in a national cohort. Journal of Cataract & Refractive Surgery. 50(3). 217–223. 1 indexed citations

Li, Yafeng, et al.. (2022). Systemic disease associations with angioid streaks in a large healthcare claims database. Eye. 37(8). 1596–1601. 6 indexed citations

10.

Meer, Elana, et al.. (2022). Recent Practice Patterns in Acute Retinal Artery Occlusions in the United States. Ophthalmic Epidemiology. 29(6). 696–702. 5 indexed citations

11.

Meer, Elana, et al.. (2022). Statin use and the risk of progression to vision threatening diabetic retinopathy. Pharmacoepidemiology and Drug Safety. 31(6). 652–660. 5 indexed citations

12.

Wubben, Thomas J., et al.. (2021). Association of metformin and development of dry age-related macular degeneration in a U.S. insurance claims database. European Journal of Ophthalmology. 32(1). 417–423. 19 indexed citations

13.

Sobrin, Lucia, et al.. (2021). Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database. Ocular Immunology and Inflammation. 30(6). 1334–1340. 4 indexed citations

14.

Sobrin, Lucia, et al.. (2021). Angiotensin Converting Enzyme-Inhibitors and Incidence of Non-infectious Uveitis in a Large Healthcare Claims Database. Ophthalmic Epidemiology. 29(1). 25–30. 1 indexed citations

15.

Tauqeer, Zujaja, Peter Bracha, Brendan McGeehan, & Brian L. VanderBeek. (2021). Hypercoagulability Testing and Hypercoagulable Disorders in Young Central Retinal Vein Occlusion Patients. Ophthalmology Retina. 6(1). 37–42. 6 indexed citations

16.

Sterling, Jacob, et al.. (2021). Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma. British Journal of Ophthalmology. 107(2). 215–220. 37 indexed citations

17.

Xia, Tian, Alexander J. Brucker, Brendan McGeehan, & Brian L. VanderBeek. (2020). Risk of non-infectious uveitis or myasthenia gravis in patients on checkpoint inhibitors in a large healthcare claims database. British Journal of Ophthalmology. 106(1). 87–90. 7 indexed citations

18.

Cui, Qi N., et al.. (2019). Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(9). 1931–1939. 15 indexed citations

19.

Tamhankar, Madhura A., Wei Pan, Gui‐Shuang Ying, et al.. (2017). Smartphone Ophthalmoscopy (D-Eye System) for Detection of Optic Nerve Pathology and Cup-to-Disc Ratio in an Outpatient Clinical Setting. Investigative Ophthalmology & Visual Science. 58(8). 4836–4836. 1 indexed citations

20.

Zheng, Yuanjie, et al.. (2016). Automated Quantification of Morphologic Features and Vasculature of Choroid on Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT). Investigative Ophthalmology & Visual Science. 57(12). 4652–4652. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact